Editor's PickYahoo Finance • 2 days ago
Catch The Final Round at 4 p.m. ET with Alexis Christoforous and markets correspondent Nicole Sinclair. Stocks bucking the tough tape today include beaten down GoPro as the action camera maker reported a revenue beat and reiterated guidance, daily deals site Groupon soaring as profit and sales topped forecasts and it increased revenue and earnings guidance, and Facebook, with shares on fire after a massive earnings beat as mobile ad sales grew and new users came to the platform.
Barrons.com • 19 hours ago
RBC's Michael Yee and team contend that biotech stocks like Amgen (AMGN), Biogen (BIIB), Celgene (CELG), Gilead Sciences (GILD), and Alexion Pharmaceuticals (ALXN) are looking past the political risks: The SPDR S&P Biotech ETF (XBI) biotech index is up +13% in a month vs S&P500 +5% and we think political rhetoric and fear about drug pricing legislation which has been one of the primary overhangs on biotech stocks could be starting to move behind us as we go into H2:16. Indeed, given the large correction in the past year and rotation out of biotech, we think the market is starting to get more comfortable with the political environment and this could be an important shift and one of the key factors in driving stocks higher and removing the overhang.
Forbes • 2 days ago
Second-quarter earnings season has been going for more than a week, and we’ve had a chance to hear from all four of the biggest companies in biotech as measured by sales, market valuation and clout. Here’s what they had to say in their business updates, along with some commentary from analysts
After hours: 112.190.00 (0.00%) as of 7:55 PM EDT
|Bid||110.00 x 100|
|Ask||112.19 x 100|
|52wk Range||92.98 - 133.59|
|Day's Range||110.50 - 112.43|
|Avg Vol (3m)||4,358,641|
As of 4:00 PM EDT. Market closed.